Cinvanti Disease Interactions
There is 1 disease interaction with Cinvanti (aprepitant).
Aprepitant (applies to Cinvanti) liver disease
Moderate Potential Hazard, Moderate plausibility.
Aprepitant is primarily metabolized by the liver. In studies of patients with mild to moderate hepatic impairment (Child-Pugh score 5 to 9), aprepitant was well tolerated and no clinically significant alterations in its pharmacokinetics were observed. Thus, no dosage adjustment of aprepitant is necessary in this patient population. However, there are no clinical or pharmacokinetic data in patients with severe hepatic impairment (Child-Pugh score > 9), and caution is advised if aprepitant is used in such patients.
Switch to professional interaction data
Cinvanti drug interactions
There are 453 drug interactions with Cinvanti (aprepitant).
Cinvanti alcohol/food interactions
There is 1 alcohol/food interaction with Cinvanti (aprepitant).
More about Cinvanti (aprepitant)
- Cinvanti consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.